#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Glioblastoma multiforme Plasma cell myeloma recurrent Phaeochromocytoma Hormone-dependent prostate cancer Fungal infection Fibrodysplasia ossificans progressiva Uveitis Marginal zone lymphoma refractory Central nervous system neoplasm Malignant peritoneal neoplasm Orthostatic hypotension Autoimmune disorder Gastrointestinal disorder Primitive neuroectodermal tumour Transient ischaemic attack More trials…

    Learn about Rare Diseases

    Cystic fibrosis lung – Basic Information Glycogen storage disease type I – Trials in Disease Waldenstrom’s macroglobulinaemia – Life with Disease Glomerulonephritis membranous – Life with Disease Prolymphocytic leukaemia – Diagnostics Thrombotic thrombocytopenic purpura – Treatment Pemphigoid – Treatment Primary immunodeficiency syndrome – Basic Information MELAS syndrome – Trials in Disease Haemophilia B with anti factor IX – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Flecainide M1P Dipotassium Salt Tumor Necrosis Factor-Alpha Histamine Dihydrochloride Ibuprofen Arginine Bleomycin Docetaxel Db-1303 Bi-1910 REGN7544 IHMA-2121771-1 Buprenorphine Artemisia Vulgaris Dl-Alpha-Tocopherol Citicoline Sodium Roginolisib Alnuctamab Pentoxifylline RO7268489 Human Coagulation Factor Vii More therapies…

    Learn about Your Condition

    Haemophilia Carcinoid tumour pulmonary Metastases to lymph nodes Red blood cell abnormality Mixed-type liposarcoma Wheezing Alagille syndrome Asplenia Short-bowel syndrome Choroid melanoma Ovarian cancer metastatic Patent ductus arteriosus Alcoholic liver disease Hypertriglyceridaemia Open angle glaucoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • A Study of MK-1084 and Drug Combination Versus Pembrolizumab and Chemotherapy for Adults with Advanced Lung Cancer with KRAS G12C Mutation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Lung neoplasm malignant
    • Non-small cell lung cancer
    Investigated Drugs:
    • Mk-1084
    • Carboplatin
    • Cisplatin
    Austria Belgium France Germany Greece Hungary +5

  • A Study of Belimumab to Help Identify Safe Kidney Transplant Matches in Patients with High Antibody Levels Against Donor Tissue Types

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Belimumab
    The Netherlands

  • A Study to Test if Rinvecalinase Alfa is Safe and Works for Treating Acute Ischemic Stroke in Patients with Moderate Stroke Severity

    Recruiting

    4 1
    Belgium France Hungary Poland Romania Spain

  • A Study of Group B Streptococcus 6-Valent Polysaccharide Conjugate Vaccine in Healthy Pregnant Women and Their Infants

    Recruiting

    3 1
    Investigated Drugs:
    • GROUP B STREPTOCOCCUS CAPSULAR POLYSACCHARIDE IB CONJUGATED TO DIPHTHERIA TOXIN CRM197
    • STREPTOCOCCUS AGALACTIAE, SEROTYPE II, CAPSULAR POLYSACCHARIDE, CONJUGATED TO CRM197
    • STREPTOCOCCUS AGALACTIAE, SEROTYPE V, CAPSULAR POLYSACCHARIDE, CONJUGATED TO CRM197
    Finland The Netherlands Spain

  • A Study Testing Bleximenib in People with Acute Leukemia

    Recruiting

    1 1 1
    Investigated Diseases:
    • Acute leukaemia
    Investigated Drugs:
    • BLEXIMENIB
    • JNJ-75276617
    Belgium France The Netherlands Spain

  • A Study Comparing RLY-2608 and Fulvestrant with Capivasertib and Fulvestrant for Patients with PIK3CA-Mutant Hormone Receptor Positive, HER2-Negative Advanced Breast Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • RLY-2608
    • Capivasertib
    • Fulvestrant
    Austria Belgium Bulgaria Czechia Denmark France +10
Previous Page
1 … 102 103 104 105 106 … 1,646
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!